KRYS - CIK 0001711279
Krystal Biotech, Inc. (KRYS) reported revenue of $389.13M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $389.13M | +33.9% |
| FY 2024 | $290.51M | +473.0% |
| FY 2023 | $50.70M | - |
| FY 2022 | $0.00 | - |
| FY 2021 | $0.00 | - |
Krystal Biotech, Inc. (KRYS) reported revenue of $389.13M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Krystal Biotech, Inc.'s revenue grew from $0.00 to $389.13M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.